Synopsis
The idiopathic rapid eye movement sleep behavior
disorder (iRBD) is a condition that often evolves into Parkinson’s disease
(PD), therefore by monitoring iRBD one can track the neurodegeneration of
individuals that may progress to PD. Here we used a battery of MRI contrasts to
characterize brain tissue properties such as microstructural integrity, iron
loads, and functional connectivity in 10 iRBD, 10 PD and 10 age-matched healthy
subjects. Rotating frame relaxation methods adiabatic T1,2ρ and RAFFn, along
with DTI and rsfMRI detected heterogeneous abnormalities in several subcortical
structures of PD and iRBD subjects.Purpose
Parkinson’s disease (PD) is associated with
abnormal synuclein protein deposits, iron deposition, gliosis and neuronal
loss. Idiopathic rapid eye movement sleep behavior disorder (iRBD) is another
condition that arises from underlying pontomedullary synuclein pathology which
then evolves into PD or another synucleinopathy in up to 90% of cases [1-6]. Therefore by monitoring iRBD one may track neurodegeneration in individuals as they progress to PD. It is thought that iRBD pathology spreads
through transmission of pathogenic forms of α-synuclein protein in a caudal-rostral manner [4], similarly to what Braak et al. proposed for PD [7]. Thus, it is crucial to have sensitive imaging methods
that can detect the heterogeneous changes that ultimately extend throughout
different brain regions and affect different cell populations. In this work we
employed a battery of MRI modalities that are sensitive to various brain tissue
properties, such as microstructural integrity, iron loads, and functional
connectivity. Namely, we used diffusion tensor imaging (DTI), our novel
rotating frame relaxation mapping methods including adiabatic T
1ρ [8], T
2ρ [9] and RAFF4 (Relaxation Along a Fictitious
Field in the rotating frame of rank 4) [10], and resting state fMRI (rsfMRI). Here we present the
results of a cross-sectional study conducted at 3T on 10 control, 10 iRBD and
10 PD subjects.
Methods
Ten mild-moderate advanced (Hoehn & Yahr
Stage I-II; on medications) individuals with PD (67±6 years, 5F/5M, UPDRS=39),
ten iRBD subjects (64±7 years, 5F/5M, UPDRS=15) and ten age-matched healthy controls (58±6 years, 4F/6M) underwent MRI using a 3 T Siemens Prisma system.
Adiabatic T
1ρ, T
2ρ and RAFF4 measurements were collected from 30 AC-PC
aligned slices covering brainstem and basal ganglia using segmented GRE
readout (4 segments), voxel size: 1.6x1.6x3.6 mm
3, GRAPPA= 3,
TE=3.18 ms; TR=2s. T
1-weighted, T
2-weighted images, DTI, T
2* and rsfMRI were
collected in a whole-brain fashion. For adiabatic relaxation measurements,
hyperbolic secant pulses were used with BW=1.6 kHz, pulse duration T
p=6
ms, ω
1max /(2π)=800 Hz, 5 acquisitions with number of pulses = 0, 4,
8, 12, 16, MLEV4 phase cycling; for RAFF4, T
p was 4.56 ms for one P-packet,
number of P-packets 0, 4, 8, 12, 16, ω
1max /(2π)=323 Hz. Parameters for T
2*: voxel size: 1.6x1.6x1.6
mm
3, 96 slices, TR=51 ms, TE=10, 19, 27, 36, 45 ms, GRAPPA 3; Flip
Angle 15
o; for DTI: 128 directions, with 5 additional non-diffusion
weighed (b
0) images, b-value=1500s/mm
2, voxel size 1.8x1.8x1.8mm
3,
TR=2820 ms, TE=72.6 ms; multi band (MB)=4; for rsfMRI: EPI, TR=900 ms, multi band
(MB)=4; TE=30 ms; voxel size=3x3x3 mm
3, matrix size=64x64, 48 AC-PC
aligned slices with interleaved slice acquisition, 502 volumes. The MRI relaxation
and DTI parameters were calculated from 12 regions of interest (ROIs) defined in subject space, and compared among the subject groups. Functional connectivity measures
were also extracted using seed analyses from 3 out of 12 ROIs, namely the caudate, substantia nigra (SN) and midbrain (regions of
primary analysis). Statistical significance of group differences
was inferred by unpaired two-tailed t-test.
Results and discussion
Statistically significant differences of MRI relaxation
and DTI parameters among groups were observed in regions of primary analysis
including SN, caudate, and midbrain (Fig. 1). Interesting differences of MRI
parameters were simultaneously observed also in other brain regions including
amygdala and parahippocampal gyrus (PG). Observed differences
of MRI relaxation and DTI parameters were consistent with neuronal degeneration
and iron accumulation in multiple brain regions [11-13]. In particular, gradual trends across controls vs iRBD
vs PD of T
2*, T
1ρ and T
2ρ in PG and caudate might suggest progression of iRBD into PD. In addition, we observed significant differences
between controls and PD of functional connectivity measures in the networks
associated with SN and midbrain (Fig. 2), in agreement with previous
observations of disrupted nigrostriatal connectivity induced by iRBD and PD [14, 15].
Conclusion
The chosen MRI modalities detect group
differences in multiple subcortical brain regions of iRBD and PD subjects vs control
individuals. Overall, having MRI techniques which are sensitive to iron, such as T
2ρ and T
2*, or
sensitive to neuronal loss such as T
1ρ, or sensitive to myelination such as RAFF4, as
well as having the ability to image extended brain coverage, is critical for
evaluating PD and iRBD. The rotating
frame adiabatic T
1ρ and T
2ρ techniques are
expected to provide greater sensitivity to detect tissue changes rapidly as
compared to conventional MRI methods.
Acknowledgements
NIH grants: P41 EB015894, P30 NS076408, UL1TR000114. Academy of Finland, Sigrid Juselius
Foundation.References
[1] Bunzeck et al. Parkinsonism Relat Disord
2013;19:1136. [2] Schenck et al. Sleep 1986;9:293. [3] Schenck et al. Neurology 1996;46:388. [4] Boeve BF. Lancet
Neurol 2013;12:469-82. [5] Boeve et al Mov Disord 2001;16:622. [6] Luk et al.
Science 2012;338:949. [7] Braak et al. Neurobiol Aging 2003;24:197. [8] Michaeli
et al. J Magn Reson 2006;181:135. [9] Michaeli et al. JMR 2004;169:293. [10]
Liimatainen et al. MRM 2014:doi: 10.1002/mrm.25129. [11] Lach et al. Acta
neuropathologica 1992;83:352. [12] Jia et al. AJNR 2015. [13] He et al. Hum
Brain Mapp 2015:doi: 10.1002/hbm.22928. [14] Ellmore et al. Sleep 2013;36:1885.
[15] Rieckmann et al. NeuroImage Clinical 2015;8:554.